Literature DB >> 25151422

Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Sunny X Tang1, James J Yi2, Tyler M Moore1, Monica E Calkins1, Christian G Kohler1, Daneen A Whinna1, Margaret C Souders3, Elaine H Zackai2, Donna M McDonald-McGinn2, Beverly S Emanuel2, Warren B Bilker1, Ruben C Gur1, Raquel E Gur4.   

Abstract

OBJECTIVE: Chromosome 22q11.2 deletion syndrome (22q11DS) confers 25% risk for psychosis and is an invaluable window for understanding the neurobiological substrate of psychosis risk. The Structured Interview for Prodromal Syndromes (SIPS) is well validated in nondeleted populations for detecting clinical risk but has only recently been applied to 22q11DS. We assessed the largest 22q11DS cohort to date and report on SIPS implementation and symptoms elicited.
METHOD: The SIPS, including its 19 subscales, was administered to 157 individuals with 22q11DS aged 8 to 25 years. Youth and caregiver interviews were conducted and rated separately, then compared for agreement. Implementation of the SIPS in 22q11DS was challenging because of the prevalence of developmental delay and comorbid conditions. However, by explaining questions and eliciting examples, we were able to help youths and caregivers understand and respond appropriately. Consensus ratings were formulated and analyzed with itemwise and factor analysis.
RESULTS: Subthreshold symptoms were common, with 85% of individuals endorsing 1 or more. The most commonly rated items were ideational richness (47%) and trouble with focus and attention (44%). Factor analysis revealed a 3-factor solution with positive, negative, and disorganized components. Youth-caregiver comparisons suggested that youths report greater symptoms of perceptual abnormalities, suspiciousness, trouble with emotional expression, and bizarre thinking. Caregivers reported more impaired tolerance to normal stress, poor hygiene, and inattention.
CONCLUSION: The SIPS was adapted for 22q11DS through comprehensive and semi-structured administration methods, yielding a high prevalence of subthreshold psychotic symptoms. The significance and predictive validity of these symptoms require future longitudinal analysis.
Copyright © 2014 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  22q11.2 deletion syndrome; Structured Interview for Prodromal Syndromes; prodromal; psychosis; schizophrenia

Mesh:

Year:  2014        PMID: 25151422      PMCID: PMC4159384          DOI: 10.1016/j.jaac.2014.05.009

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  39 in total

1.  Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Authors:  Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome.

Authors:  Maude Schneider; Martial Van der Linden; Bronwyn Glaser; Eleonora Rizzi; Sophie P Dahoun; Christine Hinard; Lucia Bartoloni; Stylianos E Antonarakis; Martin Debbané; Stephan Eliez
Journal:  Psychiatry Res       Date:  2012-02-27       Impact factor: 3.222

3.  Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Donna M McDonald-McGinn; Koen Devriendt; Maria Cristina Digilio; Paula Goldenberg; Alex Habel; Bruno Marino; Solveig Oskarsdottir; Nicole Philip; Kathleen Sullivan; Ann Swillen; Jacob Vorstman
Journal:  J Pediatr       Date:  2011-05-12       Impact factor: 4.406

4.  Factor-structure of the Italian version of the Scale Of Prodromal Symptoms (SOPS): a comparison with the English version.

Authors:  A Comparelli; V Savoja; G D Kotzalidis; S W Woods; S Mosticoni; F Vassallo; F Soscia; R Piccione; G Palma; D Pucci; P Girardi; L Conti; R Tatarelli
Journal:  Epidemiol Psychiatr Sci       Date:  2011-03       Impact factor: 6.892

5.  Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.

Authors:  D I Shapiro; J F Cubells; O Y Ousley; K Rockers; E F Walker
Journal:  Schizophr Res       Date:  2011-04-19       Impact factor: 4.939

6.  Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.

Authors:  Paula C Goldenberg; Monica E Calkins; Jan Richard; Donna McDonald-McGinn; Elaine Zackai; Nandita Mitra; Beverly Emanuel; Marcella Devoto; Karin Borgmann-Winter; Christian Kohler; Catherine G Conroy; Ruben C Gur; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-12-13       Impact factor: 3.568

7.  Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study.

Authors:  Kevin M Antshel; Robert Shprintzen; Wanda Fremont; Anne Marie Higgins; Stephen V Faraone; Wendy R Kates
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-04       Impact factor: 8.829

8.  Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.

Authors:  Joel Stoddard; Tara Niendam; Robert Hendren; Cameron Carter; Tony J Simon
Journal:  Schizophr Res       Date:  2010-01-06       Impact factor: 4.939

9.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

Authors:  Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2009-04-21       Impact factor: 9.306

10.  Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome.

Authors:  Tamar Green; Doron Gothelf; Bronwyn Glaser; Martin Debbane; Amos Frisch; Moshe Kotler; Abraham Weizman; Stephan Eliez
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-11       Impact factor: 8.829

View more
  20 in total

Review 1.  Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.

Authors:  Kerri L Tang; Kevin M Antshel; Wanda P Fremont; Wendy R Kates
Journal:  J Dev Behav Pediatr       Date:  2015-10       Impact factor: 2.225

2.  Abnormalities in white matter tracts in the fronto-striatal-thalamic circuit are associated with verbal performance in 22q11.2DS.

Authors:  Carina Heller; Saskia Steinmann; James J Levitt; Nikos Makris; Kevin M Antshel; Wanda Fremont; Ioana L Coman; Stefan R Schweinberger; Thomas Weiß; Sylvain Bouix; Marek R Kubicki; Wendy R Kates; Zora Kikinis
Journal:  Schizophr Res       Date:  2020-10-23       Impact factor: 4.939

3.  Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.

Authors:  Cynthia B Solot; Tyler M Moore; Terrence Blaine Crowley; Marsha Gerdes; Edward Moss; Daniel E McGinn; Beverly S Emanuel; Elaine H Zackai; Sean Gallagher; Monica E Calkins; Kosha Ruparel; Ruben C Gur; Donna M McDonald-McGinn; Raquel E Gur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-07-27       Impact factor: 3.568

4.  Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.

Authors:  Ehud Mekori-Domachevsky; Yael Guri; James Yi; Omri Weisman; Monica E Calkins; Sunny X Tang; Raz Gross; Donna M McDonald-McGinn; Beverly S Emanuel; Elaine H Zackai; Gil Zalsman; Abraham Weizman; Ruben C Gur; Raquel E Gur; Doron Gothelf
Journal:  Schizophr Res       Date:  2016-12-29       Impact factor: 4.939

5.  Dissociable Disruptions in Thalamic and Hippocampal Resting-State Functional Connectivity in Youth with 22q11.2 Deletions.

Authors:  Charles Schleifer; Amy Lin; Leila Kushan; Jie Lisa Ji; Genevieve Yang; Carrie E Bearden; Alan Anticevic
Journal:  J Neurosci       Date:  2018-11-26       Impact factor: 6.167

6.  The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.

Authors:  Sunny X Tang; Tyler M Moore; Monica E Calkins; James J Yi; Adam Savitt; Christian G Kohler; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Ruben C Gur; Raquel E Gur
Journal:  Biol Psychiatry       Date:  2016-09-08       Impact factor: 13.382

Review 7.  Bullying and psychosis: The impact of chronic traumatic stress on psychosis risk in 22q11.2 deletion syndrome - a uniquely vulnerable population.

Authors:  Danessa Mayo; Khalima A Bolden; Tony J Simon; Tara A Niendam
Journal:  J Psychiatr Res       Date:  2019-04-15       Impact factor: 4.791

8.  Neurodevelopmental Genomic Strategies in the Study of the Psychosis Spectrum.

Authors:  Raquel E Gur
Journal:  Nebr Symp Motiv       Date:  2016

9.  Examining the durability of a hybrid, remote and computer-based cognitive remediation intervention for adolescents with 22q11.2 deletion syndrome.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Early Interv Psychiatry       Date:  2016-09-15       Impact factor: 2.732

10.  Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts.

Authors:  James J Yi; Ronnie Weinberger; Tyler M Moore; Monica E Calkins; Yael Guri; Donna M McDonald-McGinn; Elaine H Zackai; Beverly S Emanuel; Raquel E Gur; Doron Gothelf; Ruben C Gur
Journal:  Brain Cogn       Date:  2016-05-17       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.